For example, both PTEN-mutant triple negative breast cancer (TNBC) and colorectal cancer (CRC) have higher expression of PD-L1, and PI3K inhibition induces a reduction in PD-L1 expression in tumor cells [16,17]. Here, PIK3CA is linked to neoplasm.